Helicos BioSciences Corporation Sets IPO at 5.4 Million Shares, $13-$15

May 8, 2007 |

1 min read

WASHINGTON, May 7 (Reuters) - Helicos BioSciences Corp., a genetic analysis technologies firm, set its planned initial public offering on Monday at 5.4 million shares at between $13 and $15 per share.

>>> Discuss This Story

IPO

MORE ON THIS TOPIC

Hand collage holding dollar paper money isolated on yellow background. Using cash to buy concept. Halftone effect in pop art style illustration.

Breast cancer

Novartis Buys Breast Cancer Drug for $2B to Keep Up With Myriad Rivals

March 20, 2026

·

2 min read

·

Tristan Manalac

Confrontation and opposite opinions concept. Business people hands pulling rope in opposite directions in office showing power and leadership vector illustration

Mergers & acquisitions

Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles

March 11, 2026

·

5 min read

·

Annalee Armstrong

Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration

Mergers & acquisitions

Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy

March 6, 2026

·

1 min read

·

Annalee Armstrong

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Cardiovascular disease

Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets

March 5, 2026

·

2 min read

·

Heather McKenzie